The upregulation of SMURF2 predicted a favorable prognosis of patients with CRC and liver metastases, and the tumor-suppressive role of SMURF2 was found to be associated with cell migration and EpCAM expression [56]. Here, SMURF2 is linked to colorectal carcinoma.